Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Profit After Tax (2019 - 2026)

Nkarta (NKTX) posted quarterly Profit After Tax of -$27.8 million for Q1 2026, up 13.04% year-over-year from -$24.6 million in Q1 2025, and down 1.54% quarter-over-quarter from -$27.4 million in Q4 2025.

Nkarta (NKTX) Profit After Tax (2019 - 2026) Analysis & Trends

Nkarta's Profit After Tax history runs 8 years deep, the most recent figure standing at -$27.8 million for Q1 2026.

  • In Q1 2026, Profit After Tax rose 13.04% year-over-year to -$27.8 million; the TTM figure through Mar 2026 stood at -$99.9 million (up 10.19% YoY), while the FY2025 annual figure was -$104.1 million, up 4.33% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$27.8 million, down from -$27.4 million in the prior quarter.
  • The five-year high for Profit After Tax was -$21.7 million in Q3 2025, with the low at -$33.3 million in Q2 2023.
  • The 5-year median for Profit After Tax is -$27.8 million (2026), against an average of -$27.8 million.
  • The sharpest annual moves came in 2022 and 2024: Profit After Tax plunged 79719.44% in 2022, then gained 24.92% in 2024.
  • Nkarta's Profit After Tax stood at -$31.9 million in 2022, then increased by 12.26% to -$28.0 million in 2023, then rose by 7.45% to -$25.9 million in 2024, then retreated by 5.68% to -$27.4 million in 2025, then dropped by 1.54% to -$27.8 million in 2026.
  • Business Quant data shows NKTX's Profit After Tax at -$27.8 million in Q1 2026, -$27.4 million in Q4 2025, and -$21.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Nkarta 201.14 Mn 201.14 Mn - -40.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.66 Mn
Mar 31, 2026 -27.83 Mn
Dec 31, 2025 -27.41 Mn
Sep 30, 2025 -21.72 Mn
Jun 30, 2025 -22.98 Mn
Mar 31, 2025 -32.01 Mn
Dec 31, 2024 -25.94 Mn
Sep 30, 2024 -28.34 Mn
Jun 30, 2024 -24.99 Mn
Mar 31, 2024 -29.52 Mn
Dec 31, 2023 -28.02 Mn
Sep 30, 2023 -25.65 Mn
Jun 30, 2023 -33.29 Mn
Mar 31, 2023 -30.82 Mn
Dec 31, 2022 -31.94 Mn
Sep 30, 2022 -28.74 Mn
Jun 30, 2022 -26.92 Mn
Mar 31, 2022 -25.99 Mn
Dec 31, 2021 -22.97 Mn
Sep 30, 2021 -36,000.00